Skip to main content

Clinical Trials Using Carmustine

Review the clinical trials studying carmustine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-13 of 13

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Status: Active
Location: 3 locations
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Thiotepa-Based Autologous Stem Cell Transplant for the Prevention of CNS-Relapse in Patients with Newly-Diagnosed High-Risk Diffuse Large B-Cell Lymphoma, CNS-PHLAT Trial
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Chemotherapy with or without Total Body Irradiation before Stem Cell Transplant in Treating Patients with Hodgkin or Non-Hodgkin Lymphoma
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Genetically Engineered Cells (P140K MGMT Hematopoietic Stem Cells), O6-Benzylguanine, Temozolomide, and Carmustine for the Treatment of Resected Supratentorial Glioblastoma or Gliosarcoma
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined with BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Pembrolizumab Before and After Autologous Stem Cell Transplant for the Treatment of Relapsed or Refractory Classical Hodgkin Lymphoma
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Tebentafusp-tebn in Combination with Liver-Directed Therapies (TACE and IE) for the Treatment of Metastatic Uveal Melanoma
Status: Active
Location: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Dapagliflozin in Combination with Standard Chemotherapy for the Treatment of Recurrent Brain Tumors or Relapsed or Refractory Solid Tumors in Pediatric Patients
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
A Study of Melphalan in People with Lymphoma Getting an Autologous Hematopoietic Cell Transplant
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Tazemetostat in Combination with CHOP for Previously Untreated Peripheral T-Cell Lymphoma
Status: Temporarily Closed to Accrual
Location: 3 locations